Statin Therapy Results in the Real World Practice in the Czech Republic

NCT ID: NCT01055977

Last Updated: 2011-08-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3253 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-02-28

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.

The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidaemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Documented statin therapy for at least 12 months
* Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ales Kminek

Role: STUDY_DIRECTOR

AstraZeneca

Jaromir Hradec

Role: PRINCIPAL_INVESTIGATOR

General faculty hospital Prague

Jan Bultas

Role: PRINCIPAL_INVESTIGATOR

Faculty hospital Kralovske Vinohrady Prague

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Benešov, , Czechia

Site Status

Research Site

Beroun, , Czechia

Site Status

Research Site

Blansko, , Czechia

Site Status

Research Site

Bohumín, , Czechia

Site Status

Research Site

Boskovice, , Czechia

Site Status

Research Site

Brandýs nad Labem, , Czechia

Site Status

Research Site

Brno, , Czechia

Site Status

Research Site

Cheb, , Czechia

Site Status

Research Site

Chomutov, , Czechia

Site Status

Research Site

Chrudim, , Czechia

Site Status

Research Site

Česká Lípa, , Czechia

Site Status

Research Site

České Budějovice, , Czechia

Site Status

Research Site

Český Krumlov, , Czechia

Site Status

Research Site

Děčín, , Czechia

Site Status

Research Site

Domažlice, , Czechia

Site Status

Research Site

Dvůr Králové nad Labem, , Czechia

Site Status

Research Site

Fryštát, , Czechia

Site Status

Research Site

Frýdek-Místek, , Czechia

Site Status

Research Site

Havířov, , Czechia

Site Status

Research Site

Havlíčkův Brod, , Czechia

Site Status

Research Site

Hradec Králové, , Czechia

Site Status

Research Site

Hustopeče, , Czechia

Site Status

Research Site

Ivančice, , Czechia

Site Status

Research Site

Jablonec nad Nisou, , Czechia

Site Status

Research Site

Jeseník, , Czechia

Site Status

Research Site

Jičín, , Czechia

Site Status

Research Site

Jihlava, , Czechia

Site Status

Research Site

Jindřichův Hradec, , Czechia

Site Status

Research Site

Karlovy Vary, , Czechia

Site Status

Research Site

Kladno, , Czechia

Site Status

Research Site

Kolín, , Czechia

Site Status

Research Site

Krnov, , Czechia

Site Status

Research Site

Kuřim, , Czechia

Site Status

Research Site

Kutná Hora, , Czechia

Site Status

Research Site

Kyjov, , Czechia

Site Status

Research Site

Liberec, , Czechia

Site Status

Research Site

Litoměřice, , Czechia

Site Status

Research Site

Louny, , Czechia

Site Status

Research Site

Mělník, , Czechia

Site Status

Research Site

Městec Králové, , Czechia

Site Status

Research Site

Mikulov, , Czechia

Site Status

Research Site

Milevsko, , Czechia

Site Status

Research Site

Mladá Boleslav, , Czechia

Site Status

Research Site

Moravská Třebová, , Czechia

Site Status

Research Site

Moravské Budějovice, , Czechia

Site Status

Research Site

Moravský Krumlov, , Czechia

Site Status

Research Site

Most, , Czechia

Site Status

Research Site

Náchod, , Czechia

Site Status

Research Site

Nový Bydžov, , Czechia

Site Status

Research Site

Olomouc, , Czechia

Site Status

Research Site

Opava, , Czechia

Site Status

Research Site

Orlová, , Czechia

Site Status

Research Site

Ostrava, , Czechia

Site Status

Research Site

Ostrov, , Czechia

Site Status

Research Site

Pardubice, , Czechia

Site Status

Research Site

Pelhřimov, , Czechia

Site Status

Research Site

Pilsen, , Czechia

Site Status

Research Site

Písek, , Czechia

Site Status

Research Site

Police nad Metují, , Czechia

Site Status

Research Site

Polička, , Czechia

Site Status

Research Site

Prachatice, , Czechia

Site Status

Research Site

Prague, , Czechia

Site Status

Research Site

Prostějov, , Czechia

Site Status

Research Site

Přerov, , Czechia

Site Status

Research Site

Přeštice, , Czechia

Site Status

Research Site

Příbram, , Czechia

Site Status

Research Site

Rakovník, , Czechia

Site Status

Research Site

Roudnice nad Labem, , Czechia

Site Status

Research Site

Rožnov pod Radhoštěm, , Czechia

Site Status

Research Site

Rychnov nad Kněžnou, , Czechia

Site Status

Research Site

Semily, , Czechia

Site Status

Research Site

Slaný, , Czechia

Site Status

Research Site

Smiřice, , Czechia

Site Status

Research Site

Sternberk, , Czechia

Site Status

Research Site

Strakonice, , Czechia

Site Status

Research Site

Sušice, , Czechia

Site Status

Research Site

Svitavy, , Czechia

Site Status

Research Site

Tábor, , Czechia

Site Status

Research Site

Teplice, , Czechia

Site Status

Research Site

Tišnov, , Czechia

Site Status

Research Site

Trutnov, , Czechia

Site Status

Research Site

Třebíč, , Czechia

Site Status

Research Site

Třinec, , Czechia

Site Status

Research Site

Turnov, , Czechia

Site Status

Research Site

Uherské Hradiště, , Czechia

Site Status

Research Site

Ústí nad Labem, , Czechia

Site Status

Research Site

Valašské Klobouky, , Czechia

Site Status

Research Site

Veselí nad Moravou, , Czechia

Site Status

Research Site

Vítkovice, , Czechia

Site Status

Research Site

Vsetín, , Czechia

Site Status

Research Site

Vysoké Mýto, , Czechia

Site Status

Research Site

Vyškov, , Czechia

Site Status

Research Site

Zlín, , Czechia

Site Status

Research Site

Znojmo, , Czechia

Site Status

Research Site

Žamberk, , Czechia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Czechia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CCZ-CRE-2009/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Statins for the Treatment of NASH
NCT04679376 ACTIVE_NOT_RECRUITING PHASE2